Louise Binder

Jan 30, 2024 | therecord.com | Louise Binder |Naheed Dosani

The federal government's commitment to table the Canada Pharmacare Act by the end of March, including the development by the Canadian Drug Agency of a national formulary of essential medicines, may well help at least some of the millions of Canadians without access to prescription medications or with insufficient prescription drug coverage. At least in theory. Louise Binder is the health policy consultant for Save Your Skin Foundation.

Jan 30, 2024 | thespec.com | Louise Binder |Naheed Dosani

The federal government’s commitment to table the Canada Pharmacare Act by the end of March, including the development by the Canadian Drug Agency of a national formulary of essential medicines, may well help at least some of the millions of Canadians without access to prescription medications or with insufficient prescription drug coverage. At least in theory. Already a Subscriber?

Jan 26, 2024 | paherald.sk.ca | Louise Binder |Naheed Dosani

by Louise Binder and Dr. Naheed Dosani The federal government’s commitment to table the Canada Pharmacare Act by the end of March 2024, including the development by the Canadian Drug Agency of a national formulary of essential medicines, may well help at least some of the millions of Canadians without access to prescription medications or with insufficient prescription drug coverage. At least in theory.

Jan 4, 2024 | healthing.ca | Louise Binder |Naheed Dosani

by Louise Binder, Save Your Skin Foundation and Dr. Naheed Dosani Share This Story Opinion: Canada needs a universal pharmacare program that doesn't leave anyone behind According to Health Canada, three million Canadians have reported not filling their prescriptions because they could not afford the cost.

Nov 29, 2023 | hospitalnews.com | Louise Binder

With top cancer research institutes and a public healthcare system, Canada is poised to be a world leader in researching and providing innovative life-saving cancer treatments, called precision or targeted therapies. But this can only happen if federal, provincial and territorial governments remove barriers and allow more cancer patients access to both treatments and the tests necessary to determine if they are candidates for precision therapies.